Table 2.
Pairwise nucleotide (5′UTR and 3′UTR), and amino acid (L, VP1-4, 2A-C, and 3A-D) identity (%) |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Bo-11-39/2009/JPN |
Bo-12-3/2009/JPNa |
||||||||||
Bat-1(NC16A) | Bat-2(MH9F) | Bat-3(TLC5F) | Feline(356F) | Canine(325F) | Bo-12-3 | Bat-1(NC16A) | Bat-2(MH9F) | Bat-3(TLC5F) | Feline(356F) | Canine(325F) | |
5′UTR | 22.2 | 22.2 | 41.7 | 20.1 | 41.9 | 57.5 | 24.2 | 24.1 | 38.5 | 23.3 | 38.5 |
L | 10.5 | 10.7 | 12.9 | 7.6 | 9.5 | 15.6 | 14.7 | 16.0 | 28.6 | 10.7 | 17.5 |
VP4 | 51.5 | 44.1 | 51.5 | 50.8 | 52.9 | 60.3 | 50.0 | 41.2 | 50.8 | 49.3 | 52.2 |
VP2 | 58.7 | 55.1 | 59.2 | 61.6 | 60.2 | 55.2 | 54.0 | 49.8 | 52.9 | 57.2 | 56.7 |
VP3 | 51.3 | 51.3 | 53.0 | 52.0 | 55.4 | 59.0 | 50.9 | 51.1 | 53.3 | 54.9 | 54.7 |
VP4 | 38.6 | 37.1 | 37.4 | 45.7 | 41.4 | 49.2 | 39.1 | 37.5 | 37.6 | 42.5 | 38.7 |
2A | 24.5 | 23.8 | 25.0 | 24.1 | 17.0 | 35.6 | 23.0 | 25.9 | 17.4 | 21.9 | 23.4 |
2B | 34.2 | 35.8 | 36.0 | 34.2 | 35.4 | 37.2 | 30.0 | 32.5 | 35.7 | 33.3 | 26.5 |
2C | 58.2 | 56.9 | 56.9 | 54.6 | 56.8 | 60.1 | 60.5 | 57.3 | 60.4 | 60.5 | 60.7 |
3A | 29.3 | 30.4 | 28.6 | 24.3 | 22.5 | 36.7 | 34.1 | 39.1 | 29.2 | 36.1 | 33.1 |
3B | 41.7 | 41.7 | 41.7 | 37.5 | 37.5 | 50.0 | 37.5 | 45.8 | 29.2 | 45.8 | 33.3 |
3C | 49.7 | 49.2 | 48.1 | 52.5 | 52.5 | 56.0 | 48.1 | 48.1 | 48.1 | 49.2 | 47.0 |
3D | 64.4 | 63.7 | 63.1 | 60.3 | 61.7 | 61.4 | 58.0 | 56.3 | 57.3 | 58.5 | 62.2 |
3'UTR | 16.2 | 18.5 | 18.4 | 22.8 | 16.0 | 26.7 | 14.8 | 18.4 | 14.2 | 20.0 | 13.3 |
5′UTR of Bo-12-3/2009/JPN is incomplete.